Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Rintek Madsen

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Archives of Physical Medicine and Rehabilitation|April 5, 2002
Reliability of muscle strength testing quantified by the intraclass correlation coefficientOle Rintek Madsen
Rheumatology International|January 5, 2018
Stability of fatigue, pain, patient global assessment and the Bath Ankylosing Spondylitis Functional Index (BASFI) in spondyloarthropathy patients with stable disease according to the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)Ole Rintek Madsen
Ugeskrift for Laeger|December 18, 2008
[Bone mineral density and fracture risk in patients with ankylosing spondylitis]Ole Rintek Madsen
Clinical Rheumatology|June 11, 2016
Stability of clinical outcome measures in rheumatoid arthritis patients with stable disease defined on the basis of the EULAR response criteriaOle Rintek Madsen
The Journal of Rheumatology|March 5, 2013
Agreement between the DAS28-CRP assessed with 3 and 4 variables in patients with rheumatoid arthritis treated with biological agents in the daily clinicOle Rintek Madsen
Ugeskrift for Laeger|October 17, 2002
[Significance of physical activity for bone mass and fracture risk in patients with rheumatoid arthritis]Ole Rintek Madsen
Clinical Rheumatology|September 30, 2011
Is DAS28-CRP with three and four variables interchangeable in individual patients selected for biological treatment in daily clinical practice?Ole Rintek Madsen
Ugeskrift for Laeger|June 2, 2011
[Ankylosing spondylitis is associated with increased cardiovascular morbidity and mortality]Ole Rintek Madsen, Jesper Lindhardsen
Ugeskrift for Laeger|September 8, 2009
[Disease-modifying anti-rheumatic drugs for treatment of ankylosing spondylitis]Ole Rintek Madsen, Charlotte Egsmose
Clinical Rheumatology|May 20, 2015
Interplay between patient global assessment, pain, and fatigue and influence of other clinical disease activity measures in patients with active rheumatoid arthritisEmilie Lund Egsmose, Ole Rintek Madsen
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Archives of Physical Medicine and Rehabilitation|April 5, 2002
Reliability of muscle strength testing quantified by the intraclass correlation coefficientOle Rintek Madsen
Rheumatology International|January 5, 2018
Stability of fatigue, pain, patient global assessment and the Bath Ankylosing Spondylitis Functional Index (BASFI) in spondyloarthropathy patients with stable disease according to the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)Ole Rintek Madsen
Ugeskrift for Laeger|December 18, 2008
[Bone mineral density and fracture risk in patients with ankylosing spondylitis]Ole Rintek Madsen
Clinical Rheumatology|June 11, 2016
Stability of clinical outcome measures in rheumatoid arthritis patients with stable disease defined on the basis of the EULAR response criteriaOle Rintek Madsen
The Journal of Rheumatology|March 5, 2013
Agreement between the DAS28-CRP assessed with 3 and 4 variables in patients with rheumatoid arthritis treated with biological agents in the daily clinicOle Rintek Madsen
Ugeskrift for Laeger|October 17, 2002
[Significance of physical activity for bone mass and fracture risk in patients with rheumatoid arthritis]Ole Rintek Madsen
Clinical Rheumatology|September 30, 2011
Is DAS28-CRP with three and four variables interchangeable in individual patients selected for biological treatment in daily clinical practice?Ole Rintek Madsen
Ugeskrift for Laeger|June 2, 2011
[Ankylosing spondylitis is associated with increased cardiovascular morbidity and mortality]Ole Rintek Madsen, Jesper Lindhardsen
Ugeskrift for Laeger|September 8, 2009
[Disease-modifying anti-rheumatic drugs for treatment of ankylosing spondylitis]Ole Rintek Madsen, Charlotte Egsmose
Clinical Rheumatology|May 20, 2015
Interplay between patient global assessment, pain, and fatigue and influence of other clinical disease activity measures in patients with active rheumatoid arthritisEmilie Lund Egsmose, Ole Rintek Madsen
Pageof 7